The endothelium and lipoproteins: Insights from recent cell biology and animal studies

Seminars in Thrombosis and Hemostasis

Volumn 26, Issue 5, 2000, Pages 521-528

  Rader, D J ^a   Dugi, K A ^a  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Atherogenesis; Endothelium; Lipids; Lipoproteins; Vascular biology

Indexed keywords

ATHEROGENESIS; ATHEROSCLEROSIS; HUMAN; LIPOPROTEIN BLOOD LEVEL; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; VASCULAR ENDOTHELIUM;

EID: 0033637681     PISSN: 00946176     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2000-13208     Document Type: Review

References (98)

1. Chylomicrons induce E-selectin and VCAM-1 expression in endothelial cells
2. Native low density lipoprotein-induced calcium transients trigger VCAM-1 and E-selectin expression in cultured human vascular endothelial cells
3. Low-density lipoprotein augments interleukin-1-induced vascular adhesion molecule expression in human endothelial cells
4. Effects of oxidized low density lipoprotein, lipid mediators and statins on vascular cell interactions
5. Monocytic cell adhesion to endothelial cells stimulated by oxidized low density lipoprotein is mediated by distinct endothelial ligands
6. Modified low density lipoprotein and its constituents augment cytokine-activated vascular cell adhesion molecule-1 gene expression in human vascular endothelial cells
7. Minimally modified low-density lipoprotein induces monocyte adhesion to endothelial connecting segment-1 by activating beta 1 integrin
8. Induction of P-selectin by oxidized lipoprotein. Separate effects on synthesis surface expression
9. Endothelial nuclear factor-kappa B and the initiation of the atherosclerotic lesion
10. Oxidized low density lipoprotein induces activation of the transcription factor NF kappa B in fibroblasts, endothelial and smooth muscle cells
11. Copper and cell-oxidized low-density lipoprotein induces activator protein 1 in fibroblasts, endothelial and smooth muscle cells
12. Lp(a) and LDL induce apoptosis in human endothelial cells and in rabbit aorta: Role of oxidative stress
13. Enzymatically modified, nonoxidized LDL induces selective adhesion and transmigration of monocytes and T-lymphocytes through human endothelial cell monolayers
14. Role of lipoproteins in growth of human adult arterial endothelial and smooth muscle cells in low lipoprotein-deficient serum
15. Native low-density lipoprotein (LDL) induces the expression of the early growth response gene-1 in human umbilical arterial endothelial cells
16. Oxidized LDL promotes vascular endothelial cell pinocytosis via a prooxidation mechanism
17. Evidence that lipoproteins are carriers of bioactive factors
18. Src family kinase activation in glycosphingolipid-rich membrane domains of endothelial cells treated with oxidised low density lipoprotein
19. Oxidized low density lipoprotein inhibits the migration of aortic endothelial cells in vitro
20. Role of lysophosphatidylcholine in the inhibition of endothelial cell motility by oxidized low density lipoprotein
21. Oxidized LDL activates fas-mediated endothelial cell apoptosis
22. Oxidized low-density lipoprotein induces apoptosis of human endothelial cells by activation of CPP32-like proteases. A mechanistic clue to the 'response to injury' hypothesis
23. Ox-LDL induces apoptosis in human coronary artery endothelial cells: Role of PKC, PTK, bcl-2, and Fas
24. Arterial injury by cholesterol oxidation products causes endothelial dysfunction and arterial wall cholesterol accumulation
25. Remnants of chylomicron and very low density lipoprotein impair endothelium-dependent vasorelaxation
26. Effects of chylomicrons and chylomicron remnants on endothelium-dependent relaxation of rat aorta
27. Membrane active lipids in remnant lipoproteins cause impairment of endothelium-dependent vasorelaxation
28. Effects of vitamin C and of a cell permeable superoxide dismutase mimetic on acute lipoprotein induced endothelial dysfunction in rabbit aortic rings
29. Mildly oxidized low-density lipoprotein impairs responses of carotid but not basilar artery in rabbits
30. Inhibitors of arterial relaxation among components of human oxidized low-density lipoproteins. Cholesterol derivatives oxidized in position 7 are potent inhibitors of endothelium-dependent relaxation
31. Vascular incorporation of alpha-tocopherol prevents endothelial dysfunction due to oxidized LDL by inhibiting protein kinase C stimulation
32. Modulation of vascular tone by low density lipoproteins: Effects on l-arginine transport and nitric oxide synthesis
33. Upregulation of VCAM-1 and ICAM-1 at atherosclerosis-prone sites on the endothelium in the apoE-deficient mouse
34. Male-associated hypertension in LDL-R deficient mice
35. Hypertension and endothelial dysfunction in apolipoprotein E knockout mice
36. Impairment of endothelium-dependent arterial relaxation by high-fat feeding in apoE-deficient mice: Toward normalization by human apoA-I expression
37. Exposure to oxidized low-density lipoprotein in vivo enhances intimal thickening and selectively impairs endothelium-dependent dilation in the rabbit
38. Cell cholesterol efflux: Integration of old and new observations provides new insights
39. High density lipoprotein and lipoprotein oxidation
40. High density lipoproteins inhibit cytokine-induced expression of endothelial cell adhesion molecules
41. Ability of reconstituted high density lipoproteins to inhibit cytokine-induced expression of vascular cell adhesion molecule-1 in human umbilical vein endothelial cells
42. Apolipoprotein E and regulation of cytokine-induced cell adhesion molecule expression in endothelial cells
43. Complexes of apoA-I with phosphatidylcholine suppress dysregulation of arterial tone by oxidized LDL
44. High-density lipoprotein increases intracellular calcium levels by releasing calcium from internal stores in human endothelial cells
45. High-density lipoprotein stimulates endothelial cell movement by a mechanism distinct from basic fibroblast growth factor
46. HDL and ApoA prevent cell death of endothelial cells induced by oxidized LDL
47. Inhibition of early atherogenesis in transgenic mice by human apolipoprorein AI
48. Apolipoprotein AI transgene corrects apolipoprotein E deficiency-induced atherosclerosis in mice
49. Human apolipoprotein A-1 gene expression increases high density lipoprotein and suppresses atherosclerosis in the apolipoprotein E-deficient mouse
50. Inhibition of atberosclerosis development in cholesterol-fed human apolipoprotein A-I-transgenic rabbits
51. Somatic gene transfer of human apoA-I inhibits atherosclerosis progression in mouse models
52. Regression of atherosclerosis induced by liver-directed gene transfer of apolipoprotein A-I in mice
53. Endothelial derived vasorelaxation is impaired in human APO A-I transgenic rabbits
54. Apo A-I inhibits foam cell formation in Apo E-deficient mice after monocyte adherence to endothelium
55. Lipoprotein lipase and lipolysis: Central roles in lipoprotein metabolism and atherogenesis
56. Structure, function and role of lipoprotein lipase in lipoprotein metabolism
57. COOH-terminal disruption of lipoprotein lipase in mice is lethal in homozygotes, but heterozygotes have elevated triglycerides and impaired enzyme activity
58. Lipoprotein lipase gene variants and risk of coronary disease: A quantitative analysis of population-based studies
59. Activities of lipoprotein lipase and hepatic triglyceride lipase in postheparin plasma of patients with low concentrations of HDL cholesterol
60. Relationship between lipoprotein lipase and high density lipoprotein cholesterol in mice: Modulation by cholesteryl ester transfer protein and dietary status
61. Induced mutant mice expressing lipoprotein lipase exclusively in muscle have subnormal triglycerides yet reduced high density lipoprotein cholesterol levels in plasma
62. Induced mutant mouse lines that express lipoprotein lipase in cardiac muscle, but not in skeletal muscle and adipose tissue, have normal plasma triglyceride and high-density lipoprotein-cholesterol levels
63. Suppression of diet-induced atherosclerosis in low density lipoprotein receptor knockout mice overexpressing lipoprotein lipase
64. Overexpressed lipoprotein lipase protects against atherosclerosis in apolipoprotein E knockout mice
65. The novel compound NO-1886 increases lipoprotein lipase activity with resulting elevation of high density lipoprotein cholesterol, and long-term administration inhibits atherogenesis in the coronary arteries of rats with experimental atherosclerosis
66. A lipoprotein lipase activator, NO-1886, improves endothelium-dependent relaxation of rat aorta associated with aging
67. Lipoprotein lipase increases lipoprotein binding to the artery wall and increases endothelial layer permeability by formation of lipolysis products
68. Macrophage lipoprotein lipase promotes foam cell formation and atherosclerosis in vivo
69. The role of hepatic lipase in lipoprotein metabolism and atherosclerosis
70. Human hepatic triglyceride lipase expression reduces high density lipoprotein and aortic cholesterol in cholesterol-fed transgenic mice
71. Overexpression of hepatic lipase in transgenic rabbits leads to a marked reduction of plasma high density lipoproteins and intermediate density lipoproteins
72. Hepatic lipase deficiency increases plasma cholesterol but reduces susceptibility to atherosclerosis in apolipoprotein E-deficient mice
73. Hepatic lipase deficiency: Clinical, biochemical, and molecular genetic characteristics
74. Hepatic lipase: New insights from genetic and metabolic studies
75. A novel endothelial-derived lipase that modulates HDL metabolism
76. Cloning of a unique lipase from endothelial cells extends the lipase gene family
77. Human lipoprotein lipase: The loop covering the catalytic site is essential for interaction with lipid substrates
78. Human hepatic and lipoprotein lipase: The loop covering the catalytic site mediates lipase substrate specificity
79. Methods for assessment of tissue sites of lipoprotein degradation
80. The phospholipase-A2 reaction leads to increased monocyte adhesion of endothelial cells via the expression of adhesion molecules
81. Molecular nature of phospholipases A2 involved in prostaglandin I2 synthesis in human umbilical vein endothelial cells. Possible participation of cytosolic and extracellular type II phospholipases A2
82. Expression of human group II phospholipase A2 in transgenic mice
83. Secretory non-pancreatic phospholipase A2: Influence on lipoprorein metabolism
84. Overexpression of secretory phospholipase A2 causes rapid catabolism and altered tissue uptake of HDL cholesteryl ester and apolipoprotein A-I
85. Role of group II secretory phospholipase A2 in atherosclerosis: 2. Potential involvement of biologically active oxidized phospholipids
86. Role of group 11 secretory phospholipase A2 in atheroscierosis. 1. Increased atherogenesis and altered lipoproteins in transgenic mice expressing group IIa phospholipase A2
87. Expression of the VLDL receptor in endothelial cells
88. Expression of LDL receptor, VLDL receptor, LDL receptor-related protein, and scavenger receptor in rabbit atherosclerotic lesions: Marked induction of scavenger receptor and VLDL receptor expression during lesion development
89. Scavenger receptors are present on rabbit aortic endothelial cells in vivo
90. Identification of scavenger receptor SR-BI as a high density lipoprotein receptor
91. CLA-1 is an 85-kD plasma membrane glycoprotein that acts as a high-affinity receptor for both native (HDL, LDL, and VLDL) and modified (OxLDL and AcLDL) lipoproteins
92. Temporal and spatial pattern of expression of the HDL receptor SR-B1 during murine embryogenesis
93. Human CD36 is a high affinity receptor for the native lipoproteins HDL, LDL, and VLDL
94. Vascular biology of CD36: Roles of this new adhesion molecule family in different disease states
95. A null mutation in murine CD36 reveals an important role in fatty acid and lipoprotein metabolism
96. An endothelial receptor for oxidized low-density lipoprotein
97. Expression of lectinlike oxidized low-density lipoprotein receptor-1 in human atherosclerotic lesions
98. Angiotensin II induces LOX-1, the human endothelial receptor for oxidized low-density lipoprotein